Publications

PROBAST – A risk-of-bias tool for prediction-modelling studies

2017

Wolff, R.; Moons, K.; Riley, R.; Whiting, P.; Westwood, M.; Collins, G.; Reitsma, J.; Kleijnen, J.; Mallett, S.

Global Evidence Summit, Cape Town, South Africa. 13-16 Sep 2017.

A proposed framework for developing quality-assessment tools

2017

Whiting, P.; Wolff, R.; Mallett, S.; Simera, I.; Savovic, J.

Global Evidence Summit, Cape Town, South Africa. 13-16 Sep 2017.

Review of quality-assessment tools in systematic reviews of cost-effectiveness analyses. Are checklists fit for purpose?

2017

Wei, C.; Armstrong, N.; Ryder, S.; Kleijnen, J.

Global Evidence Summit, Cape Town, South Africa. 13-16 Sept 2017.

Author instructions of haematology and oncology journals: a cross-sectional and longitudinal study

2017

Toews, I.; Binder, N.; Wolff, R.; von Elm, E.; Meerpohl, J.

Global Evidence Summit, Cape Town, South Africa. 13-16 Sep 2017.

Searching for systematic reviews: how easy are they to identify in biomedical databases?

2017

Stirk, L.; de Kock, S.; Noake, C.; Misso, K.; Duffy, S.; Deshpande, S.; Kleijnen, J.

Global Evidence Summit, Cape Town, South Africa. 13-16 Sep 2017.

Kleijnen Systematic Reviews Ltd Publication

Cost-effectiveness analysis of new generation coronary CT scanners for difficult-to-image patients

2017

Burgers, L.T.; Redekop, W.K.; Al, M.J.; Lhachimi, S.K.; Armstrong, N.; Walker, S.; Rothery, C.; Westwood, M.; Severens, J.L.

Eur J Health Econ; 18: 731-42.

Comparison of methodology in MTCs of treatments for multiple sclerosis

2017

Sormani, M.; Giovannoni, G.; Wolff, R.; Duffy, S.; Kinter, E.; Wakeford, C.; Hyde, R.; Kleijnen, J.; Birnie, R.

HTAi 2017 annual meeting, Rome, Italy. 17-21 Jun 2017.

Using major thesaurus terms or title and abstract only terms in embase and medline search strategies for systematic reviews: the probability of losing relevant references

2017

Bramer, W.M.; Kleijnen, J.; Franco, O.H.

ICML + EAHIL 2017, Dublin: Ireland. 12-16 Jun 2017.

Response to letter to the editor regarding “Abiraterone acetate for the treatment of chemotherapy-naïve metastatic castration-resistant prostate cancer: an evidence review group perspective of a NICE single technology appraisal”

2017

Ramaekers, B.L.T.; Riemsma, R.; Tomini, F.; van Asselt, T.; Deshpande, S.; Duffy, S.; Armstrong, N.; Severens, J.L.; Kleijnen, J.; Joore, M.A.

Pharmacoeconomics; 35: 665-7.

Searching major descriptors or words only in titles and abstracts: likelihood of losing relevant references in systematic reviews (SRS)

2017

Bramer, W.M.; Giustini, D.; Kleijnen, J.; Franco, O.H.

MLA 2017, Seattle: United States. 26-31 May 2017.

Guidance in author instructions of hematology and oncology journals: a cross sectional and longitudinal study

2017

Toews, I.; Binder, N.; Wolff, R.F.; Toprak, G.; von Elm, E.; Meerpohl, J.J.

PLoS One; 12: e0176489.

A Bayesian random effects mixed treatment comparison of daclizumab versus other disease modifying treatments for relapsing-remitting multiple sclerosis. Paper presented at 69th American Academy of Neurology Annual Meeting; 22-28 Apr 2017; Boston: United States

2017

Wakeford, C.; Birnie, R.; Wolff, R.; Kinter, E.; Sabatella, G.; Giannattasio, G.; Ye, X.; Liu, Y.; Kleijnen, J.

Neurology; 88: P6.370.

The burden, epidemiology, costs and treatment for Duchenne muscular dystrophy: an evidence review

2017

Ryder, S.; Leadley, R.M.; Armstrong, N.; Westwood, M.; de Kock, S.; Butt, T.; Jain, M.; Kleijnen, J.

Orphanet J Rare Dis; 12: 79.

Evaluation of NIHR investment in Cochrane infrastructure and systematic reviews [Internet]

2017

Misso, Kate; Kleijnen, J.; Alderson, P.; Aubin, J.; Cairns, J.; Crowe, S.; Garner, P.

National Institute for Health Research.

Feasibility and effect of home-based therapy programmes for children with cerebral palsy: a protocol for a systematic review

2017

Beckers, L.W.; Schnackers, M.L.; Janssen-Potten, Y.J.; Kleijnen, J.; Steenbergen, B.

BMJ Open; 7: e013687.

Can incontinence be cured? A systematic review of cure rates

2017

Riemsma, R.; Hagen, S.; Kirschner-Hermanns, R.; Norton, C.; Wijk, H.; Andersson, K.E.; Chapple, C.; Spinks, J.; Wagg, A.; Hutt, E.; Misso, K.; Deshpande, S.; Kleijnen, J.; Milsom, I.

BMC Med; 15: 63.

Abiraterone acetate for the treatment of chemotherapy-naïve metastatic castration-resistant prostate cancer: an evidence review group perspective of an NICE single technology appraisal

2017

Ramaekers, B.L.T.; Riemsma, R.; Tomini, F.; van Asselt, T.; Deshpande, S.; Duffy, S.; Armstrong, N.; Severens, J.L.; Kleijnen, J.; Joore, M.A.

Pharmacoeconomics; 35: 191-202.

A systematic review to assess adherence and persistence with statins

2017

Deshpande, S.; Quek, R.G.; Forbes, C.A.; de Kock, S.; Kleijnen, J.; Gandra, S.R.; Simpson, R.J.

Curr Med Res Opin; 33: 769-78.

How to prepare a systematic review of economic evaluations for informing evidence-based healthcare decisions: a five-step approach (part 1/3)

2016

van Mastrigt, G.A.; Hiligsmann, M.; Arts, J.J.; Broos, P.H.; Kleijnen, J.; Evers, S.M.; Majoie, M.H.

Expert Rev Pharmacoeconomics Outcomes Res; 16: 689-704.

How to prepare a systematic review of economic evaluations for clinical practice guidelines: database selection and search strategy development (part 2/3)

2016

Thielen, F.W.; van Mastrigt, G.A.; Burgers, L.T.; Bramer, W.M.; Majoie, M.H.; Evers, S.M.; Kleijnen, J.

Expert Rev Pharmacoeconomics Outcomes Res; 16: 705-721.

Not all Cochrane reviews are good quality systematic reviews. Paper presented at ISPOR 19th Annual European Congress; 29 Oct-2 Nov 2016; Vienna: Austria

2016

Deshpande, S.; Misso, K.; Westwood, M.; Stirk, L.; de Kock, S.; Kleijnen, J.; Clayton, D.; Kleijnen, J.

Value Health; 19: A371.

A systematic review of cardiovascular outcomes-based cost-effectiveness analyses of lipid-lowering therapies

2016

Wei, C-Y.; Quek, R. G. W.; Villa, G.; Gandra, S.R.; Forbes, C.A.; Ryder, S.; Armstrong, N.; Deshpande, S.; Duffy, S.; Kleijnen, J.; Lindgren, P.

Pharmacoeconomics; 35: 297-318.

The predictive value of haemodynamic parameters for outcome of deep venous reconstructions in patients with chronic deep vein obstruction – A systematic review

2016

Kurstjens, R.; de Wolf, M.; Kleijnen, J.; de Graaf, R.; Wittens, C.

Phlebology; 32: 532-42.

Comparative effectiveness of biologics for the management of rheumatoid arthritis: systematic review and network meta-analysis

2016

Alfonso-Cristancho, R.; Armstrong, N.; Arjunji, R.; Riemsma, R.; Worthy, G.; Ganguly, R.; Kleijnen, J.

Clin Rheumatol; 36: 25-34.

Stay Informed

PROBAST – A risk-of-bias tool for prediction-modelling studies

A proposed framework for developing quality-assessment tools

Review of quality-assessment tools in systematic reviews of cost-effectiveness analyses. Are checklists fit for purpose?

Author instructions of haematology and oncology journals: a cross-sectional and longitudinal study

Searching for systematic reviews: how easy are they to identify in biomedical databases?

Cost-effectiveness analysis of new generation coronary CT scanners for difficult-to-image patients

Comparison of methodology in MTCs of treatments for multiple sclerosis

Using major thesaurus terms or title and abstract only terms in embase and medline search strategies for systematic reviews: the probability of losing relevant references

Response to letter to the editor regarding “Abiraterone acetate for the treatment of chemotherapy-naïve metastatic castration-resistant prostate cancer: an evidence review group perspective of a NICE single technology appraisal”

Searching major descriptors or words only in titles and abstracts: likelihood of losing relevant references in systematic reviews (SRS)

Guidance in author instructions of hematology and oncology journals: a cross sectional and longitudinal study

A Bayesian random effects mixed treatment comparison of daclizumab versus other disease modifying treatments for relapsing-remitting multiple sclerosis. Paper presented at 69th American Academy of Neurology Annual Meeting; 22-28 Apr 2017; Boston: United States

The burden, epidemiology, costs and treatment for Duchenne muscular dystrophy: an evidence review

Evaluation of NIHR investment in Cochrane infrastructure and systematic reviews [Internet]

Feasibility and effect of home-based therapy programmes for children with cerebral palsy: a protocol for a systematic review

Can incontinence be cured? A systematic review of cure rates

Abiraterone acetate for the treatment of chemotherapy-naïve metastatic castration-resistant prostate cancer: an evidence review group perspective of an NICE single technology appraisal

A systematic review to assess adherence and persistence with statins

How to prepare a systematic review of economic evaluations for informing evidence-based healthcare decisions: a five-step approach (part 1/3)

How to prepare a systematic review of economic evaluations for clinical practice guidelines: database selection and search strategy development (part 2/3)

Not all Cochrane reviews are good quality systematic reviews. Paper presented at ISPOR 19th Annual European Congress; 29 Oct-2 Nov 2016; Vienna: Austria

A systematic review of cardiovascular outcomes-based cost-effectiveness analyses of lipid-lowering therapies

The predictive value of haemodynamic parameters for outcome of deep venous reconstructions in patients with chronic deep vein obstruction – A systematic review

Comparative effectiveness of biologics for the management of rheumatoid arthritis: systematic review and network meta-analysis